Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Monopar Therapeutics
Biotech
AZ licenses discarded rare disease drug to Monopar Therapeutics
Monopar Therapeutics is recovering a drug from the scrap heap of AstraZeneca’s rare disease pipeline, licensing Wilson disease candidate ALXN-1840.
Kevin Dunleavy
Oct 24, 2024 2:54pm
Rallybio reins in preclinical, Monopar pivots to radiopharma
May 9, 2024 10:13am
Monopar spikes chemo side effect drug after phase 2/3 analysis
Mar 28, 2023 11:33am
Monopar Therapeutics puts the brakes on IPO, again
Nov 8, 2019 8:30am
